PROCTER-SYNTEX's LEVE OTC NAPROXEN WILL APPEAR ON-SHELF THIS SPRING FOLLOWING FDA APPROVAL JAN. 11; OTC DOSAGE REGIMEN REFLECTS ADVISORY CMTE. CONCERNS
Executive Summary
Procter-Syntex Health Products company's Aleve brand of OTC naproxen sodium will appear on retail shelves this spring following FDA approval of the Rx-to-OTC switch application on Jan. 11.